Working Together to Prevent Pharmaceutical Counterfeiting

Post by:
  • 3:40PM Dec 13, 2013
  • Comments off

Counterfeit drugs are a significant threat — to patient safety, to public health, to supply chain integrity — raising concerns over potential liability for consumers, manufacturers, distributors, pharmacies, governments, and other entities. As supply chains become more complex and global, efforts to combat the use of counterfeit drugs pose new challenges. In 2010 alone, counterfeit […]

Read More

The Global Supply Chain: Risky Business for Pharmaceutical Ingredients

Post by:
  • 1:17PM Apr 15, 2013
  • Comments off

By Crystal Morrison, Ph.D. Diversity within the global supply chain may provide competitive benefits for industry, but its complicated nature may also mask risk and liability. Recent headlines regarding adulterated pharmaceuticals have provided a sobering reminder of the importance of supply chain security and quality control. While regulatory agencies are doing what they can to […]

Read More

RJ Lee Group Provides Training to the U.S. FDA on Managing Foreign Particulate Contamination in Pharmaceuticals

Post by:
  • 11:24AM Sep 28, 2012
  • Comments off

(MONROEVILLE, Pa., September 28, 2012) Members of RJ Lee Group, Inc.’s Biotechnology and Pharmaceutical Services Department conducted a training seminar for U.S. Food and Drug Administration (FDA) field inspectors entitled “Managing Foreign Particulate Investigations.”  The seminar, presented by forensic scientists Ms. Karen Smith, Ms. Julia Patterson, and Mr. Michael Gorski, focused on proactive measures for […]

Read More

RJ Lee Group Scientists Publish Article on Nanotechnology in International Journal of Pharmaceutical Sciences and Nanotechnology

Post by:
  • 11:12AM Jun 05, 2012
  • Comments off

(MONROEVILLE, Pa., May 5, 2012) Three scientists at RJ Lee Group, Inc., an industrial forensic laboratory and consulting firm headquartered in Monroeville, PA, co-authored an article on the integration of nanotechnology that will be published in the International Journal of Pharmaceutical Sciences and Nanotechnology.  Dr. Kristin L. Bunker, Senior Scientist, Ms. Julianne Wolfe, Manager of […]

Read More

Dr. Linxian (Lin) Wu Joins RJ Lee Group BioPharma Group as Director

Post by:
  • 9:29AM Apr 04, 2011
  • Comments off

(MONROEVILLE, PA – April 4, 2011)  RJ Lee Group welcomes Dr. Lin Wu as Director of Pharmaceutical and Biotechnical Services at their Monroeville headquarters. As Director, Dr. Wu will be expanding RJ Lee Group’s forensic approach to biopharma foreign particulate identification and characterization as well as nanotechnology efforts in materials characterization pertaining to product R&D […]

Read More

Journal of Oncology Pharmacy Practice (JOPP) Publishes Article on Hazardous Drug Preparation Systems Co-Authored by RJ Lee Group Scientists

Post by:
  • 9:28AM Mar 07, 2011
  • Comments off

Matthew D. Zock, CIH and Senior Scientist Keith P. Rickabaugh of RJ Lee Group, Inc. co-authored an article with Scott Soefje of the University of Texas Health Science Center that was published in the March 2011 issue of the Journal of Oncology Pharmacy Practice (JOPP). The article on closed-system transfer devices (CSTDs) is titled “Evaluation […]

Read More

Materials Experts

Post by:
  • 5:32PM Feb 15, 2019
  • Comments off

Our experts work in a wide variety of technical areas, and therefore support multiple industries and types of services that RJLG provides. For ease of navigation, our experts are listed in their most active areas of service to RJLG clientele, but a more detailed description of each staff member’s experience and expertise can be found […]

Read More